Department of Dermatology, Mayo Clinic, Scottsdale, AZ, USA.
University of Arizona College of Medicine - Tucson, Tucson, AZ, USA.
J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1450-1455. doi: 10.1111/jdv.14712. Epub 2017 Dec 18.
The benign and malignant patterns of acral melanocytic naevi (AMN) and acral melanomas (AM) have been defined in a series of retrospective studies. A three-step algorithm was developed to determine when to biopsy acral melanocytic lesions. This algorithm has only been applied to a Japanese population.
Our study aimed to review the current management strategy of acral melanocytic lesions and to investigate the utility of the three-step algorithm in a predominately Caucasian cohort.
A retrospective search of the pathology and image databases at Mayo Clinic was performed between the years 2006 and 2016. Only cases located on a volar surface with dermoscopic images were included. Two dermatologists reviewed all dermoscopic images and assigned a global dermoscopic pattern. Clinical and follow-up data were gathered by chart review. All lesions with known diameter and pathological diagnosis were used for the three-step algorithm.
Regular fibrillar and ridge patterns were more likely to be biopsied (P = 0.01). The majority of AMN (58.1%) and AM (60%) biopsied were due to physician-deemed concerning dermoscopic patterns. 39.2% of these cases were parallel furrow, lattice-like or regular fibrillar. When patients were asked to follow-up within a 3- to 6-month period, only 16.7% of the patients returned within that interval. The three-step algorithm would have correctly identified four of five AM for biopsy, missing a 6 mm, multicomponent, invasive melanoma.
We found one major educational gap in the recognition of low-risk lesions with high rates of biopsy of the fibrillary pattern. Recognizing low-risk dermoscopic patterns could reduce the rate of biopsy of AMN by 23.3%. We identified two major practice gaps, poor patient compliance with follow-up and the potential insensitivity of the three-step algorithm to small multicomponent acral melanocytic lesions.
在一系列回顾性研究中,已经定义了肢端黑色素细胞痣(AMN)和肢端黑色素瘤(AM)的良性和恶性模式。已经开发出一种三步算法来确定何时对肢端黑色素细胞病变进行活检。该算法仅应用于日本人群。
我们的研究旨在回顾当前肢端黑色素细胞病变的管理策略,并研究三步算法在以白种人为主的队列中的应用。
在 2006 年至 2016 年间,对梅奥诊所的病理和图像数据库进行了回顾性搜索。仅包括位于掌侧表面且具有皮肤镜图像的病例。两名皮肤科医生审查了所有皮肤镜图像,并分配了一个整体皮肤镜模式。通过病历回顾收集临床和随访数据。所有具有已知直径和病理诊断的病变都用于三步算法。
规则纤维状和脊状模式更有可能进行活检(P=0.01)。由于医生认为有问题的皮肤镜模式,大多数 AMN(58.1%)和 AM(60%)被活检。这些病例中有 39.2%为平行沟、格子状或规则纤维状。当要求患者在 3 至 6 个月的时间内进行随访时,只有 16.7%的患者在该时间段内返回。三步算法将正确识别出五个 AM 中的四个进行活检,漏诊了一个 6 毫米、多成分、侵袭性黑色素瘤。
我们发现,在识别具有高纤维状模式活检率的低风险病变方面存在一个主要的教育差距。识别低风险皮肤镜模式可以将 AMN 的活检率降低 23.3%。我们发现了两个主要的实践差距,即患者随访的依从性差和三步算法对小的多成分肢端黑色素细胞病变的潜在不敏感性。